Figure 1.
The design and characterization of EV tracking system. (A) Schematic of EV tracking system. This system consisted of donor A549 cells that expressed sgRNAs and Cas9 proteins and recipient cells that contained STOP-FP elements. (B) Schematic of the recuperation of FP expression in reporter cells. (C) Schematic of engineered EVs. FP Nb and its affinitive Nb were fused with exosomal membrane protein CD63 and Cas9 proteins, respectively. Cas9 proteins were captured by EVs through the bond of FP-FP Nb, selectively being sorted into EVs. (D) qRT-PCR analysis of sgRNA pair levels in EVs derived from wild-type A549 or donor A549 cells (n = 3 in each group). (E) Western blot analysis of Cas9 protein levels in EVs derived from wild-type A549 cells or donor A549 cells (n = 3 in each group). (F) RNA immunoprecipitation (IP) assay of exosomal Cas9 and sgRNAs derived from wild-type A549 cells or donor A549 cells. Cas9 proteins were tagged with Flag. Lysates of EVs were blotted using Flag antibody (input) or immunoprecipitated with Flag and blotted using Flag antibody (IP). IP with anti-IgG served as control. (G) sgRNAs analysis of immunoprecipitants following IP assay in (F). Abbreviations: EV: extracellulaer vesicle; FP: fluorescent protein; Nb: nanobody; sgRNAs: single-guide RNAs.
